Literature DB >> 29614651

Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.

Yanmin Zhang1,2, Ouyang Guo1, Yuda Huo1, Guan Wang1, Heng-Ye Man1,3.   

Abstract

As the primary mediator for synaptic transmission, AMPA receptors (AMPARs) are crucial for synaptic plasticity and higher brain functions. A downregulation of AMPAR expression has been indicated as one of the early pathological molecular alterations in Alzheimer's disease (AD), presumably via amyloid-β (Aβ). However, the molecular mechanisms leading to the loss of AMPARs remain less clear. We report that in primary neurons, application of Aβ triggers AMPAR internalization accompanied with a decrease in cell-surface AMPAR expression. Importantly, in both Aβ-treated neurons and human brain tissue from AD patients, we observed a significant decrease in total AMPAR amount and an enhancement in AMPAR ubiquitination. Consistent with facilitated receptor degradation, AMPARs show higher turnover rates in the presence of Aβ. Furthermore, AD brain lysates and Aβ-incubated neurons show increased expression of the AMPAR E3 ligase Nedd4 and decreased expression of AMPAR deubiquitinase USP46. Changes in these enzymes are responsible for the Aβ-dependent AMPAR reduction. These findings indicate that AMPAR ubiquitination acts as the key molecular event leading to the loss of AMPARs and thus suppressed synaptic transmission in AD.

Entities:  

Keywords:  AMPA receptor; Alzheimer’s disease; Nedd4; USP46; amyloid-β; degradation; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29614651      PMCID: PMC6353779          DOI: 10.3233/JAD-170879

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  38 in total

Review 1.  AMPA receptor trafficking and synaptic plasticity.

Authors:  Roberto Malinow; Robert C Malenka
Journal:  Annu Rev Neurosci       Date:  2002-03-04       Impact factor: 12.449

Review 2.  Regulation of AMPA receptors during synaptic plasticity.

Authors:  Insuk Song; Richard L Huganir
Journal:  Trends Neurosci       Date:  2002-11       Impact factor: 13.837

Review 3.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 4.  Receptor trafficking and synaptic plasticity.

Authors:  Graham L Collingridge; John T R Isaac; Yu Tian Wang
Journal:  Nat Rev Neurosci       Date:  2004-12       Impact factor: 34.870

5.  Activity-dependent dynamics and sequestration of proteasomes in dendritic spines.

Authors:  Baris Bingol; Erin M Schuman
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

6.  AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.

Authors:  Eric H Chang; Mary J Savage; Dorothy G Flood; Justin M Thomas; Robert B Levy; Veeravan Mahadomrongkul; Tomoaki Shirao; Chiye Aoki; Patricio T Huerta
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

7.  AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Authors:  Helen Hsieh; Jannic Boehm; Chihiro Sato; Takeshi Iwatsubo; Taisuke Tomita; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

Review 8.  Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.

Authors:  F M S de Vrij; D F Fischer; F W van Leeuwen; E M Hol
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

9.  Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.

Authors:  Troy L Carter; Robert A Rissman; Amanda J Mishizen-Eberz; Barry B Wolfe; Ronald L Hamilton; Sam Gandy; David M Armstrong
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

10.  Regulation of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit.

Authors:  Heng-Ye Man; Yoko Sekine-Aizawa; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

View more
  19 in total

Review 1.  Deubiquitylating enzymes in neuronal health and disease.

Authors:  Fatima Amer-Sarsour; Alina Kordonsky; Yevgeny Berdichevsky; Gali Prag; Avraham Ashkenazi
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

Review 2.  Research Progress on Alzheimer's Disease and Resveratrol.

Authors:  Yan Yan; Huihuang Yang; Yuxun Xie; Yuanlin Ding; Danli Kong; Haibing Yu
Journal:  Neurochem Res       Date:  2020-03-11       Impact factor: 3.996

3.  MK0677, a Ghrelin Mimetic, Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.

Authors:  Jing Tian; Tienju Wang; Qi Wang; Lan Guo; Heng Du
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.

Authors:  Na Liu; Miao-Miao Lin; Yan Wang
Journal:  Mol Neurobiol       Date:  2022-10-19       Impact factor: 5.682

5.  Disarranged neuroplastin environment upon aging and chronic stress recovery in female Sprague Dawley rats.

Authors:  Marta Balog; Senka Blažetić; Vedrana Ivić; Irena Labak; Bartosz Krajnik; Raquel Marin; Ana Canerina-Amaro; Daniel Pereda de Pablo; Ana Bardak; Robert Gaspar; Kálmán Ferenc Szűcs; Sandor G Vari; Marija Heffer
Journal:  Eur J Neurosci       Date:  2021-05-14       Impact factor: 3.698

Review 6.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

7.  A kinetic model for Brain-Derived Neurotrophic Factor mediated spike timing-dependent LTP.

Authors:  Sergio M G Solinas; Elke Edelmann; Volkmar Leßmann; Michele Migliore
Journal:  PLoS Comput Biol       Date:  2019-04-24       Impact factor: 4.475

8.  The Acute Effects of Amyloid-Beta1-42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus.

Authors:  Jason H Y Yeung; Thulani H Palpagama; Warren P Tate; Katie Peppercorn; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  Front Neurosci       Date:  2020-01-17       Impact factor: 4.677

9.  PTEN Is Required for The Anti-Epileptic Effects of AMPA Receptor Antagonists in Chronic Epileptic Rats.

Authors:  Ji-Eun Kim; Hana Park; Ji-Eun Lee; Tae-Hyun Kim; Tae-Cheon Kang
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 10.  Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer's Disease.

Authors:  Ashok N Hegde; Spencer G Smith; Lindsey M Duke; Allison Pourquoi; Savannah Vaz
Journal:  Front Aging Neurosci       Date:  2019-12-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.